3.0.0
171
2025-12-05T08:03:03Z
2025-12-05T08:03:03Z
House
H
HR
2023-01-09
118
https://www.congress.gov/bill/118th-congress/house-bill/171
[Congressional Record Volume 169, Number 7 (Monday, January 9, 2023)][House]From the Congressional Record Online through the Government Publishing Office [www.gpo.gov]By Mr. GRIFFITH:H.R. 171.Congress has the power to enace this legislation pursuantto the following:This bill is enacted pursuant to the power granted toCongress under Article I, Section 8 of the United StatesConstitution[Page H111]
- hsif00
Energy and Commerce Committee
House
Standing
  - hsif14
Health Subcommittee
    - Referred to
2023-01-20T21:41:57Z
  - Referred To
2023-01-09T22:14:35Z
- hsju00
Judiciary Committee
House
Standing
  - Referred To
2023-01-09T22:14:40Z

- SAFE Act
118
568
HR
2023-02-03
Referred to the Subcommittee on Health.
  - Related bill
CRS

- Stopping Overdoses of Fentanyl Analogues Act
118
600
S
2023-03-01
Read twice and referred to the Committee on the Judiciary.
  - Related bill
CRS

- CEASE Overdose Act of 2023
118
1580
HR
2023-03-24
Referred to the Subcommittee on Health.
  - Related bill
CRS

- Federal Initiative to Guarantee Health by Targeting Fentanyl Act
118
3629
HR
2023-05-26
Referred to the Subcommittee on Health.
  - Related bill
CRS

- HALT Fentanyl Act
118
467
HR
2023-05-30
Received in the Senate and Read twice and referred to the Committee on the Judiciary.
  - Identical bill
CRS

- HALT Fentanyl Act
118
1141
S
2023-03-30
Read twice and referred to the Committee on the Judiciary.
  - Identical bill
CRS
- 2023-01-20
  - hsif14
Health Subcommittee
1
House committee actions
Referred to the Subcommittee on Health.
Committee
- 2023-01-09
Referred to the Committee on Energy and Commerce, and in addition to the Committee on the Judiciary, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
IntroReferral
H11100
2
House floor actions
  - hsju00
Judiciary Committee
- 2023-01-09
Referred to the Committee on Energy and Commerce, and in addition to the Committee on the Judiciary, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
IntroReferral
H11100
2
House floor actions
  - hsif00
Energy and Commerce Committee
- 2023-01-09
Introduced in House
IntroReferral
Intro-H
9
Library of Congress
- 2023-01-09
Introduced in House
IntroReferral
1000
9
Library of Congress
- G000568
Rep. Griffith, H. Morgan [R-VA-9]
H.
Griffith
R
VA
Morgan
9
N
- L000566
Rep. Latta, Robert E. [R-OH-5]
Robert
Latta
R
OH
E.
5
2023-01-09
True
- F000475
Rep. Finstad, Brad [R-MN-1]
Brad
Finstad
R
MN
1
2023-02-01
False
Crime and Law Enforcement
- Administrative law and regulatory procedures
2023-02-17T17:00:23Z
- Department of Justice
2023-02-17T17:00:23Z
- Drug trafficking and controlled substances
2023-02-17T17:00:23Z
- Licensing and registrations
2023-02-17T17:00:23Z
- Research administration and funding
2023-02-17T17:00:23Z
Crime and Law Enforcement
2023-01-20T14:45:23Z
00
2023-01-09
Introduced in House
2023-02-13T12:10:13Z
Halt All Lethal Trafficking of Fentanyl Act or the HALT Fentanyl Act
This bill places fentanyl-related substances as a class into schedule I of the Controlled Substances Act. A schedule I controlled substance is a drug, substance, or chemical that has a high potential for abuse; has no currently accepted medical value; and is subject to regulatory controls and administrative, civil, and criminal penalties under the Controlled Substances Act.
Additionally, the bill establishes a new, alternative registration process for schedule I research that is funded by the Department of Health and Human Services or the Department of Veterans Affairs or that is conducted under an investigative new drug exemption from the Food and Drug Administration.
The bill also makes several other changes to registration requirements for conducting research with controlled substances, including
- permitting a single registration for related research sites in certain circumstances,
- waiving the requirement for a new inspection in certain situations, and
- allowing a registered researcher to perform certain manufacturing activities with small quantities of a substance without obtaining a manufacturing registration.

HALT Fentanyl Act
- Display Title
45

HALT Fentanyl Act
2024-07-24T15:24:11Z
- Short Title(s) as Introduced
101

HALT Fentanyl Act
2024-05-24T13:43:09Z
Introduced in House
IH
- Short Title(s) as Introduced
101

Halt All Lethal Trafficking of Fentanyl Act
2024-05-24T13:43:09Z
Introduced in House
IH
- Official Title as Introduced
6

To amend the Controlled Substances Act with respect to the scheduling of fentanyl-related substances, and for other purposes.
2024-03-18T20:10:30Z
Introduced in House
IH
- Introduced in House
2023-01-09T05:00:00Z
  - https://www.govinfo.gov/content/pkg/BILLS-118hr171ih/xml/BILLS-118hr171ih.xml
2023-01-20
Referred to the Subcommittee on Health.
text/xml
EN
Pursuant to Title 17 Section 105 of the United States Code, this file is not subject to copyright protection and is in the public domain.
Congressional Research Service, Library of Congress
This file contains bill summaries and statuses for federal legislation. A bill summary describes the most significant provisions of a piece of legislation and details the effects the legislative text may have on current law and federal programs. Bill summaries are authored by the Congressional Research Service (CRS) of the Library of Congress. As stated in Public Law 91-510 (2 USC 166 (d)(6)), one of the duties of CRS is "to prepare summaries and digests of bills and resolutions of a public general nature introduced in the Senate or House of Representatives". For more information, refer to the User Guide that accompanies this file.